Financhill
Back

Neurocrine Biosciences Stock Predictions

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.
Buy
70

NBIX
Neurocrine Biosciences

Last Price:
137.49
Seasonality Move:
8.72%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

Neurocrine Biosciences Stock Forecast

  • Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 31.3% based on the past 27 years of stock performance.
  • Neurocrine Biosciences has risen higher in 17 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.96%
  • Is Neurocrine Biosciences Stock Undervalued?
    The current Neurocrine Biosciences [NBIX] share price is $137.48. The Score for NBIX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Neurocrine Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 31.3% based on the past 27 years of stock performance.

Neurocrine Biosciences Stock Rating

Buy
70
Neurocrine Biosciences (NBIX) is a Buy

Is Neurocrine Biosciences overpriced?

  • Neurocrine Biosciences has risen higher in 17 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.96%

Neurocrine Biosciences Stock Price History

Is NBIX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com

52-Week Data

52-Week High:
148.37
52-Week Low:
89.04

Prediction Charts

Market Cap:
13.68B
Price in USD:
137.48
Volume:
800.99K
Beta:
0.78

Technical Analysis

SMA50:
136.76
SMA100:
134.38
SMA200:
121.82
52-Wk Change:
36.06%

Stock Predictions

  • Is Neurocrine Biosciences stock public?
    Yes, Neurocrine Biosciences is a publicly traded company.
  • What is the Neurocrine Biosciences stock quote today?
    The Neurocrine Biosciences stock price is 137.48 USD today.
  • How to buy Neurocrine Biosciences stock online?
    You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-11 138.03 135.93 138.67 135.28
Apr-12 136.22 134.65 137.78 134.63
Apr-15 134.97 131.74 137.00 131.52
Apr-16 131.78 132.99 135.18 131.49
Apr-17 133.11 133.37 134.44 131.36
Apr-18 133.23 132.54 134.20 131.00
Apr-19 132.65 131.96 133.65 130.13
Apr-22 132.48 133.70 134.18 131.79
Apr-23 141.00 140.25 145.00 139.22
Apr-24 140.89 138.97 144.70 138.01
Apr-25 139.37 137.76 139.37 136.06
Apr-26 137.47 135.99 138.63 135.17
Apr-29 136.05 138.89 139.37 136.05
Apr-30 138.07 137.48 140.47 137.34

Neurocrine Biosciences Earnings

Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurocrine Biosciences Forecast Revenue Growth

Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.88 per share, and an increase next year of $1.78 per share.

* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.